Human immune signatures of Dengue virus and Mycobacterium Tuberculosis exposure in infection, disease and vaccination

NIH RePORTER · NIH · U19 · $292,800 · view on reporter.nih.gov ↗

Abstract

Our group has developed a set of data standards over the years to capture different aspects of immune profiling studies that enable the description of, for example, the immune exposure being studied (e.g. type and course of infection or vaccination) or the molecular markers measured in a cytometry assay and how they relate detected cells to specific cell types. These standards were primarily developed for the Human Immunology Project Consortium (HIPC), and were tailored to be interoperable with the ImmPort submission system, in which they have been adopted and are now used for all data submissions into ImmPort. For HIPC, these standards have enabled cross-center data analysis projects and method development. As part of this work, automated validation routines have been created that test ImmPort data submissions for their adherence to these data standards, which has enabled us to identify and correct issues in data submissions..

Key facts

NIH application ID
10228367
Project number
3U19AI118626-06S1
Recipient
LA JOLLA INSTITUTE FOR IMMUNOLOGY
Principal Investigator
Alessandro Sette
Activity code
U19
Funding institute
NIH
Fiscal year
2020
Award amount
$292,800
Award type
3
Project period
2020-09-02 → 2022-05-31